The Madras Medical Mission is a hospital located in Chennai. The first unit of the hospital was set up in 1987. The hospital houses 300 beds including 76 intensive care beds.

There are 300 beds in Madras Medical Mission.

During the past decade, Madras Medical Mission conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Madras Medical Mission" #1 sponsor was "Abbott Medical Devices" with 5 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Adocia" with 1 trials sponsored, "Biotronik AG" with 1 trials sponsored and "Concept Medical Inc." with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Madras Medical Mission" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Cardialysis BV" with 1 trials as a collaborator and "Virchow Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Madras Medical Mission" are "Coronary Artery Disease" (9 trials), "Acute Coronary Syndrome" (2 trials), "Coronary Disease" (2 trials), "Coronary Restenosis" (2 trials) and "Heart Failure" (2 trials). Many other conditions were trialed in "Madras Medical Mission" in a lesser frequency.

Most popular intervention types in "Madras Medical Mission" are "Device" (9 trials), "Drug" (5 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Empagliflozin" (3 trials), "Placebo" (3 trials), "ABSORB BVS" (1 trials), "Abluminus DES+ Sirolimus Eluting Stent System (SES)" (1 trials) and "BioChaperone PDGF-BB" (1 trials). Other intervention names were less common.

The vast majority of trials in "Madras Medical Mission" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Madras Medical Mission". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Madras Medical Mission, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Madras Medical Mission, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".